SCOPUS 정보 검색 플랫폼

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 10, Issue 2, 1998, Pages 224-226

A preliminary study of D-cycloserine treatment in Alzheimer's disease

(3) Tsai, Guochuan E a,b Falk, William E a Gunther, Jeanette a

a MASSACHUSETTS GENERAL HOSPITAL (United States)

b MCLEAN HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; GLUTAMATE RECEPTOR; GLYCINE; N METHYL DEXTRO ASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031798987 PISSN: 08950172 EISSN: None Source Type: Journal
DOI: 10.1176/jnp.10.2.224 Document Type: Article

Times cited : (32)

References (15)

1
- 0026705242
- Treatment for Alzheimer's disease?
- Growdon JH: Treatment for Alzheimer's disease? N Engl J Med 1992; 327:1306-1308
- (1992) N Engl J Med , vol.327 , pp. 1306-1308
- Growdon, J.H.¹

2
- 0002383048
- Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate
- Deutsch SI, Morihisa JM: Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate. Clin Neuropharmacol 1988; 11:18-35
- (1988) Clin Neuropharmacol , vol.11 , pp. 18-35
- Deutsch, S.I.¹ Morihisa, J.M.²

3
- 0025054474
- Antemortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease
- Lowe SL, Bowen DM, Francis PT, et al: Antemortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neurosci 1990; 38:571-577
- (1990) Neurosci , vol.38 , pp. 571-577
- Lowe, S.L.¹ Bowen, D.M.² Francis, P.T.³

4
- 0024402260
- 3H]MK-801 binding in Alzheimer's disease
- 3H]MK-801 binding in Alzheimer's disease. J Neurochem 1989; 53:698-740
- (1989) J Neurochem , vol.53 , pp. 698-740
- Procter, A.W.¹ Wong, E.H.F.² Stratmann, G.C.³

5
- 0026539328
- Competitive and non-competitiveNMDA receptor antagonists in spatial learning tasks
- Bischoff D, Tiedtke PI: Competitive and non-competitiveNMDA receptor antagonists in spatial learning tasks. Eur J Pharmacol 1992; 213:269-273
- (1992) Eur J Pharmacol , vol.213 , pp. 269-273
- Bischoff, D.¹ Tiedtke, P.I.²

6
- 0025737794
- Milacemide enhances memory storage and alleviates spontaneous forgetting in mice
- Quartermain D, Nuygen T, Sheu J, et al: Milacemide enhances memory storage and alleviates spontaneous forgetting in mice. Pharmacol Biochem Behav 1991; 39:31-35
- (1991) Pharmacol Biochem Behav , vol.39 , pp. 31-35
- Quartermain, D.¹ Nuygen, T.² Sheu, J.³

7
- 0025933566
- D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain
- Chessell I, Procter A, Francis P, et al: D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain. Brain Res 1991; 565:345-348
- (1991) Brain Res , vol.565 , pp. 345-348
- Chessell, I.¹ Procter, A.² Francis, P.³

8
- 0026671647
- Hippocampus-dependent learning facilitated by a monoclonal antibody or d-cycloserine
- Thompson LT, Moskal JR, Disterjoft JF: Hippocampus-dependent learning facilitated by a monoclonal antibody or d-cycloserine. Nature 1992; 359:638-641
- (1992) Nature , vol.359 , pp. 638-641
- Thompson, L.T.¹ Moskal, J.R.² Disterjoft, J.F.³

9
- 0026388912
- Effects of NMDA modulation in scopolamine dementia
- Jones RW, Wesnes KA, Kirby J: Effects of NMDA modulation in scopolamine dementia. Ann NY Acad Sci 1991; 640:241-244
- (1991) Ann NY Acad Sci , vol.640 , pp. 241-244
- Jones, R.W.¹ Wesnes, K.A.² Kirby, J.³

10
- 0021271971
- Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
- McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
- (1984) Neurology , vol.34 , pp. 939-944
- McKhann, G.¹ Drachman, D.² Folstein, M.³

11
- 0016775648
- Cerebral blood flow in dementia
- Hachinski VC, Hiff LD, Zalkha E: Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637
- (1975) Arch Neurol , vol.32 , pp. 632-637
- Hachinski, V.C.¹ Hiff, L.D.² Zalkha, E.³

12
- 0029116094
- A dose finding trial of D-cycloserine added to neuroleptic for negative symptoms in schizophrenia
- Goff DC, Tsai G, Monoach DS, et al: A dose finding trial of D-cycloserine added to neuroleptic for negative symptoms in schizophrenia. Am J Psychiatry 1995; 152:1213-1215
- (1995) Am J Psychiatry , vol.152 , pp. 1213-1215
- Goff, D.C.¹ Tsai, G.² Monoach, D.S.³

13
- 0007539443
- Colorimetric determination of cycloserine, a new antibiotic
- Jones LR: Colorimetric determination of cycloserine, a new antibiotic. Anal Chem 1956; 28:39
- (1956) Anal Chem , vol.28 , pp. 39
- Jones, L.R.¹

14
- 0028842708
- Evaluation of cycloserine in the treatment of Alzheimer's disease
- Fakouhi TD, Jhee SS, Sramek JJ, et al: Evaluation of cycloserine in the treatment of Alzheimer's disease. J Geriatr Psychiatry Neurol 1995; 8:226-230
- (1995) J Geriatr Psychiatry Neurol , vol.8 , pp. 226-230
- Fakouhi, T.D.¹ Jhee, S.S.² Sramek, J.J.³

15
- 0028048327
- D-cycloserine treatment of Alzheimer disease
- Randolph C, Roberts JW, Tierney MC, et al: D-cycloserine treatment of Alzheimer disease. Alzheimer Dis Assoc Disord 1994; 8:198-205
- (1994) Alzheimer Dis Assoc Disord , vol.8 , pp. 198-205
- Randolph, C.¹ Roberts, J.W.² Tierney, M.C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.